A Comparative Double Blind Trial of Pimozide and Fluphenazine in Chronic Schizophrenia
- 1 December 1970
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 117 (541) , 683-684
- https://doi.org/10.1192/bjp.117.541.683
Abstract
Pimozide is a new neuroleptic drug and is chemically described as bis-para-fluoro-phenyl-butylpiperidine. It is active after oral administration, with a 24 hour duration of action and a peak effect lasting four to six hours (1). Superiority over placebo has been demonstrated by Brugmans (2).Keywords
This publication has 0 references indexed in Scilit: